Sri Trang Gloves (Thailand) Valuation
Is STGT-F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of STGT-F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: STGT-F (THB8.6) is trading above our estimate of fair value (THB2.46)
Significantly Below Fair Value: STGT-F is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for STGT-F?
Other financial metrics that can be useful for relative valuation.
What is STGT-F's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿35.53b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.7x |
Enterprise Value/EBITDA | 17.2x |
PEG Ratio | 1.9x |
Price to Earnings Ratio vs Peers
How does STGT-F's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 22.9x | ||
TOG Thai Optical Group | 11.3x | n/a | ฿4.8b |
BCH Bangkok Chain Hospital | 30.8x | 13.2% | ฿45.1b |
CHG Chularat Hospital | 28.8x | 12.3% | ฿30.4b |
RAM Ramkhamhaeng Hospital | 20.7x | 9.9% | ฿29.6b |
STGT-F Sri Trang Gloves (Thailand) | 67x | 35.9% | ฿35.5b |
Price-To-Earnings vs Peers: STGT-F is expensive based on its Price-To-Earnings Ratio (67x) compared to the peer average (22.9x).
Price to Earnings Ratio vs Industry
How does STGT-F's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?
Price-To-Earnings vs Industry: STGT-F is expensive based on its Price-To-Earnings Ratio (67x) compared to the Asian Medical Equipment industry average (24x).
Price to Earnings Ratio vs Fair Ratio
What is STGT-F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 67x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate STGT-F's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.